Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 23 articles: HTML format

Single Articles

April 2025
1. KUSAMURA S, Cinquini M, Morris D, Piso P, et al
   Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Diffuse Malignant Peritoneal Mesothelioma: A GRADE Approach for Evidence Evaluation and Recommendation.
   J Surg Oncol. 2025;131:810-815.
   PubMed     Abstract available
   
   
   March 2025
2. SONODA D, Maruyama R, Kondo Y, Mitsuhashi S, et al
   Clinical Course After Radical Local Therapy for Oligo-Recurrence of Nonsmall Cell Lung Cancer.
   J Surg Oncol. 2025 Mar 30. doi: 10.1002/jso.28032.
   PubMed     Abstract available
   
   
   
3. JIMENEZ M, Flandes J, van der Heijden EHFM, Ng CSH, et al
   Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection.
   J Surg Oncol. 2025 Mar 28. doi: 10.1002/jso.28110.
   PubMed     Abstract available
   
   
   February 2025
4. DRIGOTAS C, Loftus AW, Ammori JB, Rothermel LD, et al
   Perfusion Strategies for Cytoreductive Surgery With Heated Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.
   J Surg Oncol. 2025;131:310-315.
   PubMed     Abstract available
   
   
   January 2025
5. FENG Y, Feng H, Ye J
   Economic Toxicity Associated With Cancer Treatments: Commentary on "Relationship of Surgical Approach With Financial Toxicity in Patients With Resected Lung Cancer".
   J Surg Oncol. 2025 Jan 8. doi: 10.1002/jso.28040.
   PubMed    
   
   
   December 2024
6. WOO W, Park B, Ahadi A, Chung LI, et al
   The Role of Pulmonary Metastasectomy for Non-Primary Lung Cancer: Umbrella Review of Meta-Analyses.
   J Surg Oncol. 2024 Dec 15. doi: 10.1002/jso.28033.
   PubMed     Abstract available
   
   
   
7. DEBOEVER N, Eisenberg M, Niu J, Graber W, et al
   Conditional Survival of Patients With Early-Stage Non-Small Cell Lung Cancer Who Undergo Lobectomy, Segmentectomy, or Wedge Resection Using the NCDB.
   J Surg Oncol. 2024 Dec 5. doi: 10.1002/jso.27907.
   PubMed     Abstract available
   
   
   November 2024
8. SU YD, Ma R, Fu YB, Wu HL, et al
   Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.
   J Surg Oncol. 2024;130:1225-1234.
   PubMed     Abstract available
   
   
   October 2024
9. VITELLO DJ, Logan CD, Zaza NN, Bates KR, et al
   Comparison of a Risk Calculator With Frailty Indices in Patients Undergoing Lung Cancer Resection.
   J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27861.
   PubMed     Abstract available
   
   
   
10. NAKAO M, Suzuki A, Ichinose J, Matsuura Y, et al
    Risk of Death From Other Diseases in Lung Cancer Patients After Sublobar Resection Versus Lobectomy.
    J Surg Oncol. 2024 Oct 2. doi: 10.1002/jso.27927.
    PubMed     Abstract available
    
    
    September 2024
11. SCHIAVON M, Cannone G, Bertolaccini L, Gallina FT, et al
    Safety and Efficacy of Salvage Surgery after Treatment With Immune-Checkpoint Adjuvant Inhibitors for Advanced Non-Small Cell Lung Cancer: A Multicentric Study.
    J Surg Oncol. 2024 Sep 24. doi: 10.1002/jso.27920.
    PubMed     Abstract available
    
    
    
12. DEBOEVER N, Eisenberg MA, Antonoff MB, Hofstetter WL, et al
    Relationship of Surgical Approach With Financial Toxicity in Patients With Resected Lung Cancer.
    J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27870.
    PubMed     Abstract available
    
    
    
13. SONG KJ, Faith I, Tuminello S, Taioli E, et al
    Patients With Surgically Resectable Lung Cancer Who Opt for Radiation Have Worse Outcomes.
    J Surg Oncol. 2024 Sep 10. doi: 10.1002/jso.27873.
    PubMed     Abstract available
    
    
    
14. LIANG XL, Li XB, Fu YB, Su YD, et al
    Research progress of malignant peritoneal mesothelioma with paraneoplastic syndrome: A review.
    J Surg Oncol. 2024;130:533-542.
    PubMed     Abstract available
    
    
    
15. DE ALMEIDA DPA, Malta MFB, Cardoso WM, Leite ALDS, et al
    Metastatic benign leiomyoma: A case report of an uncommon presentation.
    J Surg Oncol. 2024;130:951-954.
    PubMed     Abstract available
    
    
    August 2024
16. VITELLO DJ, Logan CD, Zaza NN, Bates KR, et al
    Comparison of a risk calculator with frailty indices in patients undergoing lung cancer resection.
    J Surg Oncol. 2024 Aug 29. doi: 10.1002/jso.27815.
    PubMed     Abstract available
    
    
    July 2024
17. FILHO GVM, Costa GJ, Martins MR, Torres LC, et al
    Circulating levels of galectin-9 are a potential biomarker of survival in advanced non-small-cell lung cancer.
    J Surg Oncol. 2024 Jul 24. doi: 10.1002/jso.27758.
    PubMed     Abstract available
    
    
    
18. MAMEDE I, Ribeiro L, Stecca C, Escalante-Romero L, et al
    Survival and pulmonary function in stage IA non-small cell lung cancer after sublobar resection versus lobectomy: An updated meta-analysis.
    J Surg Oncol. 2024 Jul 9. doi: 10.1002/jso.27767.
    PubMed     Abstract available
    
    
    
19. PORTO DM, Costa GJ, Torres LC, Casarini DE, et al
    Immune checkpoint expression as prognostic biomarker candidates in non-small cell lung carcinoma patients.
    J Surg Oncol. 2024 Jul 7. doi: 10.1002/jso.27763.
    PubMed     Abstract available
    
    
    March 2024
20. SAIKIA J, Malik PS, Kumar S, Jain D, et al
    Can cell-free DNA (cfDNA) in pleural lavage serve as a predictive and prognostic biomarker among surgically treated Stage I-III a nonsmall cell lung cancer (NSCLC)? A pilot study.
    J Surg Oncol. 2024 Mar 4. doi: 10.1002/jso.27610.
    PubMed     Abstract available
    
    
    January 2024
21. PEZESHKIAN F, McAllister M, Singh A, Theeuwen H, et al
    What's new in thoracic oncology.
    J Surg Oncol. 2024;129:128-137.
    PubMed     Abstract available
    
    
    December 2023
22. GUPTA S, Wells SL, Jose AM, Seitter RH, et al
    High-dose IV magnesium in mesothelioma patients receiving surgery with hyperthermic intraoperative cisplatin: Pilot studies and design of a phase II randomized clinical trial.
    J Surg Oncol. 2023;128:1141-1149.
    PubMed     Abstract available
    
    
    October 2023
23. DEBOEVER N, Bayley EM, Eisenberg MA, Hofstetter WL, et al
    Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.
    J Surg Oncol. 2023 Oct 24. doi: 10.1002/jso.27490.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.